Rapid Cardiac Biomarker Test

Myoglobin (MYO)/Creatine Kinase-MB (CK-MB)/Cardiac Troponin I (cTnI) Combo Rapid Test (Whole Blood/Serum/Plasma)

Name: Myoglobin (MYO)/Creatine Kinase-MB (CK-MB)/Cardiac Troponin I (cTnI) Combo Rapid Test (Whole Blood/Serum/Plasma)
Brand: reOpenTest
SKU: CRD-3MBS0
Availability: InStock

Simultaneous detection of Myoglobin, CK-MB, and cTnI for rapid AMI assessment.

CE Certified

ISO 13485

Request Quote View Specs

Main image of Myoglobin (MYO)/Creatine Kinase-MB (CK-MB)/Cardiac Troponin I (cTnI) Combo Rapid Test (Whole Blood/Serum/Plasma)

Why Choose reOpenTest Cardiology Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Triple Marker Detection

Simultaneously detects Myoglobin, CK-MB, and cTnI for enhanced diagnostic accuracy.

Rapid Results

Provides qualitative results within 10-15 minutes for timely clinical decisions.

Multiple Sample Types

Suitable for use with whole blood, serum, or plasma samples.

Product Overview

The Myoglobin/CK-MB/cTnI Combo Rapid Test is a point-of-care immunochromatographic assay for the qualitative detection of Myoglobin, Creatine Kinase-MB, and Cardiac Troponin I in whole blood, serum, or plasma. It is intended for use in professional settings as an aid in the diagnosis of myocardial infarction.

Technical Specifications

Detection Target	Myoglobin (MYO), Creatine Kinase-MB (CK-MB), Cardiac Troponin I (cTnI)
Sample Type	Whole Blood, Serum, Plasma
Methodology	Immunochromatography
Detection Range	Qualitative (Positive/Negative)
Reaction Time	10-15 minutes
Storage Conditions	2-30u00b0C
Shelf Life	18 months

Procedure & Interpretation

Step-by-Step Procedure

Add 3 drops of sample to the test well.
Wait 10-15 minutes.
Read the results. Do not interpret after 15 minutes.

Result Interpretation

Positive: A visible band in the test region(s) (T) and the control region (C) indicates a positive result for the respective biomarker(s).

Negative: A visible band only in the control region (C) indicates a negative result for all biomarkers.

Invalid: If no band appears in the control region (C), the test is invalid and should be repeated with a new device.

Frequently Asked Questions

Simultaneous testing enhances diagnostic accuracy in AMI, as these biomarkers rise at different times post-infarction, providing a more comprehensive assessment.

As a qualitative test, it doesn't provide exact biomarker concentrations. Clinical correlation with other diagnostic information is necessary for definitive diagnosis.

The test results should be interpreted by a trained healthcare professional, in conjunction with patient history, clinical signs, and other laboratory findings to make informed medical decisions.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Myoglobin (MYO)/Creatine Kinase-MB (CK-MB)/Cardiac Troponin I (cTnI) Combo Rapid Test (Whole Blood/Serum/Plasma)